EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study

Long Hai, Shuaiwei Liu, Lina Ma, Xiangchun Ding, Xiaoyang Bai, Xia Luo iD

Technology in Cancer Research & Treatment · 2024

DOI: 10.1177/15330338241250315 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Long Hai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ningxia Natural Science Foundation, Ningxia Key Research and Development Program, Ningxia Natural Science Foundation Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This is a retrospective study aimed at comparing the clinical efficacy and safety between drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE) and conventional TACE (C-TACE) in the treatment of unresectable hepatocellular carcinoma.

Methods

From July 2019 to April 2021, we enrolled 282 patients with unresectable hepatocellular carcinoma who were admitted to our hospital, of which 179 and 103 were in the DEB-TACE and C-TACE groups, respectively. General information was collected, and treatment effects were evaluated following the modified Response Evaluation Criteria in Solid Tumors. To compare the indexes of liver and kidney function, routine blood and coagulation were collected before treatment, and 1 day, 1 month, 3 months, and 6 months postoperatively. Postoperative adverse reactions (ie, fever, nausea, vomiting, anorexia, abdominal pain) were recorded to evaluate the safety of treatment. The two groups’ progression-free survival and overall survival were also calculated to assess the treatment effect.

Results

Preoperatively, the bilirubin, transaminase, and absolute neutrophil values between the two groups were not statistically significant ( P > .05). At 1 month postoperatively, the absolute neutrophil values were significantly higher in the DEB-TACE group than those in the C-TACE group ( P < .05). At 3 months postoperatively, AST, total bilirubin, and direct bilirubin levels were significantly elevated in the DEB-TACE group ( P < .05), compared with the C-TACE group. However, at 6 months postoperatively, total and direct bilirubin levels in the C-TACE group were higher than those in the DEB-TACE group, showing a statistically significant difference ( P < .05). For patients undergoing DEB-TACE, the survival risk was lower compared to those undergoing C-TACE. The survival risk of patients undergoing DEB-TACE was lower than that of C-TACE within 20 months postoperatively. The survival risk of patients undergoing DEB-TACE was lower than that of patients undergoing C-TACE.

Conclusion

DEB-TACE may be superior to C-TACE in terms of safety and efficacy in the treatment of unresectable hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticHumansMaleFemaleRetrospective StudiesMiddle AgedTreatment OutcomeAgedAdult

Stichwörter der Autor:innen

efficacyembolizable drug-carrying microsphereshepatocellular carcinomasafetytranscatheter hepatic artery chemoembolization

Autor:innen und Institutionen

  • Department of Infectious Diseases, General Hospital of Ningxia Medical University, Yinchuan, China.
  • College of Clinical Medical, Ningxia Medical University, Yinchuan, China.

ORCID-Profile: Xia Luo

Förderung

  • Ningxia Natural Science Foundation
  • Ningxia Key Research and Development Program
  • Ningxia Natural Science Foundation Key Project

Zitieren

APA

Hai, L., Liu, S., Ma, L., Ding, X., Bai, X., & Luo, X. (2024). Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241250315

Vancouver

Hai L, Liu S, Ma L, Ding X, Bai X, Luo X. Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241250315

BibTeX
@article{Hai2024,
  author = {Hai, Long and Liu, Shuaiwei and Ma, Lina and Ding, Xiangchun and Bai, Xiaoyang and Luo, Xia},
  title = {Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  doi = {10.1177/15330338241250315}
}
Kostenlos starten →